Richard Whitley to Herpesvirus 1, Human
This is a "connection" page, showing publications Richard Whitley has written about Herpesvirus 1, Human.
Connection Strength
4.598
-
Gastric herpes simplex virus type 1 infection is associated with functional gastrointestinal disorders in the presence and absence of comorbid fibromyalgia: a pilot case-control study. Infection. 2022 Oct; 50(5):1303-1311.
Score: 0.700
-
CLINICAL PRACTICE. Genital Herpes. N Engl J Med. 2016 Aug 18; 375(7):666-74.
Score: 0.473
-
Herpes Simplex Virus Infections of the Central Nervous System. Continuum (Minneap Minn). 2015 Dec; 21(6 Neuroinfectious Disease):1704-13.
Score: 0.450
-
Changing epidemiology of herpes simplex virus infections. Clin Infect Dis. 2013 Feb; 56(3):352-3.
Score: 0.363
-
Current management and recommendations for access to antiviral therapy of herpes labialis. J Clin Virol. 2012 Jan; 53(1):6-11.
Score: 0.335
-
Treatment of herpes simplex virus infections in pediatric patients: current status and future needs. Clin Pharmacol Ther. 2010 Nov; 88(5):720-4.
Score: 0.314
-
Oncolytic HSV-1 for the treatment of brain tumours. Herpes. 2006 Nov; 13(3):66-71.
Score: 0.240
-
Neonatal herpes should be a reportable disease. Sex Transm Dis. 2005 Sep; 32(9):521-5.
Score: 0.221
-
Introduction: Is viral shedding a surrogate marker for transmission of genital herpes? Antiviral Res. 2004 Aug; 63 Suppl 1:S3-9.
Score: 0.205
-
Oncolytic herpes simplex virus immunotherapy for brain tumors: current pitfalls and emerging strategies to overcome therapeutic resistance. Oncogene. 2019 08; 38(34):6159-6171.
Score: 0.144
-
Evaluation of genetically engineered herpes simplex viruses as oncolytic agents for human malignant brain tumors. Cancer Res. 1997 Apr 15; 57(8):1502-9.
Score: 0.124
-
Evaluation of the safety and biodistribution of M032, an attenuated herpes simplex virus type 1 expressing hIL-12, after intracerebral administration to aotus nonhuman primates. Hum Gene Ther Clin Dev. 2014 Mar; 25(1):16-27.
Score: 0.100
-
A phase 1 trial of oncolytic HSV-1, G207, given in combination with radiation for recurrent GBM demonstrates safety and radiographic responses. Mol Ther. 2014 May; 22(5):1048-55.
Score: 0.100
-
Production of bioactive soluble interleukin-15 in complex with interleukin-15 receptor alpha from a conditionally-replicating oncolytic HSV-1. PLoS One. 2013; 8(11):e81768.
Score: 0.098
-
A genome-wide comparative evolutionary analysis of herpes simplex virus type 1 and varicella zoster virus. PLoS One. 2011; 6(7):e22527.
Score: 0.083
-
An update on short-course intermittent and prevention therapies for herpes labialis. Herpes. 2007 Jun; 14 Suppl 1:13A-18A.
Score: 0.062
-
Serial passage through human glioma xenografts selects for a Deltagamma134.5 herpes simplex virus type 1 mutant that exhibits decreased neurotoxicity and prolongs survival of mice with experimental brain tumors. J Virol. 2006 Aug; 80(15):7308-15.
Score: 0.059
-
The spectrum of genital herpes simplex virus infection in men attending a sexually transmitted disease clinic. J Infect Dis. 2006 Apr 01; 193(7):905-11.
Score: 0.057
-
Enhanced inhibition of syngeneic murine tumors by combinatorial therapy with genetically engineered HSV-1 expressing CCL2 and IL-12. Cancer Gene Ther. 2005 Apr; 12(4):359-68.
Score: 0.054
-
HSV shedding. Antiviral Res. 2004 Aug; 63 Suppl 1:S19-26.
Score: 0.051
-
Neonatal herpes simplex virus infection. Curr Opin Infect Dis. 2004 Jun; 17(3):243-6.
Score: 0.051
-
The use of a genetically engineered herpes simplex virus (R7020) with ionizing radiation for experimental hepatoma. Gene Ther. 2002 Jan; 9(1):75-80.
Score: 0.043
-
Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors. Proc Natl Acad Sci U S A. 2000 Feb 29; 97(5):2208-13.
Score: 0.038
-
Effect of recombinant human interferon alpha B/D (rHu-IFN-alpha B/D) in combination with acyclovir in experimental HSV-1 encephalitis. Antiviral Res. 1999 Nov; 44(1):75-8.
Score: 0.037
-
Ionizing radiation improves survival in mice bearing intracranial high-grade gliomas injected with genetically modified herpes simplex virus. Clin Cancer Res. 1999 Jun; 5(6):1517-22.
Score: 0.036
-
Genotypic and Phenotypic Diversity of Herpes Simplex Virus 2 within the Infected Neonatal Population. mSphere. 2019 02 27; 4(1).
Score: 0.035
-
Application of competitive PCR to cerebrospinal fluid samples from patients with herpes simplex encephalitis. J Clin Microbiol. 1998 Aug; 36(8):2229-34.
Score: 0.034
-
Differential effect of recombinant human and mouse interferons on replication of herpes simplex virus type 1 in mouse cells. Antiviral Res. 1996 Aug; 32(1):27-34.
Score: 0.029
-
Herpes simplex virus in African American heterosexual males: the roles of age and male circumcision. Sex Transm Dis. 2010 Apr; 37(4):217-22.
Score: 0.019
-
Inhibition of herpesvirus replication by 5-substituted 4'-thiopyrimidine nucleosides. Antimicrob Agents Chemother. 2009 Dec; 53(12):5251-8.
Score: 0.018
-
Short-course therapy for recurrent genital herpes and herpes labialis. J Fam Pract. 2007 Jan; 56(1):30-6.
Score: 0.015
-
Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics. 2001 Aug; 108(2):223-9.
Score: 0.010